Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hoepner

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Therapeutische Umschau. Revue Therapeutique|July 29, 2022
[Hypogammaglobulinemia and Multiple Sclerosis - An Overlooked Correlation?]Lara Diem, Robert Hoepner
Journal of Neurosurgery. Pediatrics|December 6, 2014
Out-of-body experience and epilepsyRobert Hoepner, Christian Brandt
Therapeutics and Clinical Risk Management|March 2, 2016
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsIlya Ayzenberg, Robert Hoepner, Ingo Kleiter
Frontiers in Neurology|April 10, 2023
Editorial: Demyelinating neurological syndromes: The role of autoimmunityMaria Eleftheria Evangelopoulos, Robert Hoepner, Clio Mavragani
BMC Medicine|April 6, 2025
Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event dataMarine Massy, Stefanie Marti, Helly Hammer, et al.
Therapeutische Umschau. Revue Therapeutique|April 3, 2019
[Progress in the treatment of multiple sclerosis]Andrew Chan, Nicole Kamber, Robert Hoepner, et al.
Frontiers in Immunology|May 22, 2020
A Brief Review of the Effects of Vitamin D on Multiple SclerosisAndrei Miclea, Maud Bagnoud, Andrew Chan, et al.
Pharmacopsychiatry|February 2, 2018
Intramuscular Testosterone Supplementation Ameliorates Depression in Hypogonadal Men: A Retrospective Study in an Outpatient DepartmentAndrei Miclea, Marius Miclea, Maximilian Pistor, et al.
The Neurologist|July 18, 2015
Dagibatran Etexilate: Is There Any Need for Coagulation Monitoring After Initiation?Robert Hoepner, Volker Behrendt, Saskia Meves, et al.
Journal of Central Nervous System Disease|May 24, 2014
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosisRobert Hoepner, Simon Faissner, Anke Salmen, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Therapeutische Umschau. Revue Therapeutique|July 29, 2022
[Hypogammaglobulinemia and Multiple Sclerosis - An Overlooked Correlation?]Lara Diem, Robert Hoepner
Journal of Neurosurgery. Pediatrics|December 6, 2014
Out-of-body experience and epilepsyRobert Hoepner, Christian Brandt
Therapeutics and Clinical Risk Management|March 2, 2016
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerationsIlya Ayzenberg, Robert Hoepner, Ingo Kleiter
Frontiers in Neurology|April 10, 2023
Editorial: Demyelinating neurological syndromes: The role of autoimmunityMaria Eleftheria Evangelopoulos, Robert Hoepner, Clio Mavragani
BMC Medicine|April 6, 2025
Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event dataMarine Massy, Stefanie Marti, Helly Hammer, et al.
Therapeutische Umschau. Revue Therapeutique|April 3, 2019
[Progress in the treatment of multiple sclerosis]Andrew Chan, Nicole Kamber, Robert Hoepner, et al.
Frontiers in Immunology|May 22, 2020
A Brief Review of the Effects of Vitamin D on Multiple SclerosisAndrei Miclea, Maud Bagnoud, Andrew Chan, et al.
Pharmacopsychiatry|February 2, 2018
Intramuscular Testosterone Supplementation Ameliorates Depression in Hypogonadal Men: A Retrospective Study in an Outpatient DepartmentAndrei Miclea, Marius Miclea, Maximilian Pistor, et al.
The Neurologist|July 18, 2015
Dagibatran Etexilate: Is There Any Need for Coagulation Monitoring After Initiation?Robert Hoepner, Volker Behrendt, Saskia Meves, et al.
Journal of Central Nervous System Disease|May 24, 2014
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosisRobert Hoepner, Simon Faissner, Anke Salmen, et al.
Pageof 13